Latest News about PBYI
Recent news which mentions PBYI
12 Health Care Stocks Moving In Friday's Intraday Session
November 25, 2022
From Benzinga
From Benzinga
Why Puma Biotechnology's Shares Jumped 20% on Monday
November 21, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
From Benzinga
Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings
November 17, 2022
From Benzinga
S&P 500 Down 1%; Crude Oil Drops Sharply
November 17, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 04, 2022
From Benzinga
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
September 21, 2022
From Benzinga
Why Puma Biotechnology Shares Dropped 17.7% This Week
September 01, 2022
Tickers
PBYI
From Motley Fool
From Benzinga
69 Biggest Movers From Friday
June 06, 2022
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 13, 2022
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
From Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
January 13, 2022
From Benzinga
Puma Biotech's Nerlynx Included In NCCN Guidelines For Breast Cancer
January 13, 2022
Tickers
PBYI
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 12, 2022
From Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.